Bringing tissue repair to life

Videregen is a leader in the development of personalised, regenerative products to replace, repair and restore organs and tissues.

We are a clinical-stage regenerative medicine company using our proprietary technology platform to develop a range of personalised regenerative products treating chronic, life-threatening orphan indications.

Videregen’s programmes are focused on the development of a portfolio of orphan medicinal products with a lead clinical indication targeting life-threatening complications following lung surgery, and lead preclinical development project focussed on thymus related (immune) diseases and disorders.

Find out more about our technology here. Or watch our technology explainer video below.